If a buyout were to occur, which is a likely event given that the company would be moving into a phase III, obviously if the phase 2 study results are positive and this being one of the greatest unmet markets in healthcare (in the last 10 years no new AZ drugs have been fda approved)...roughly what do you think a fair buyout price would be?

Is the next CC happening around the end of June?

A 1 for 10 only if they were to RS at this pps and that's not going to happen. With the announcement of another generic, completion of the Phase III and submission of the NDA, there is no way this will stay at these levels. I honestly think by year end this stock will be in the dollar area, which is very realistic

Hi Im new to this board and just picked up a small position. The company looks to be in good shape and a robust pipeline with their lead candidate in Phase 2a being completed by Dec '15. Also doesn't look like they would implement any RS as they with naturally progress to the NASDAQ.

The open house PR is a good thing however, what this company really needs is the confirmation that the 3K order has been shipped, that is truly the only way for this pps to start rising.

Does anyone know what the RS would be....from looking at past Press Releases I saw that in 2011 they approved the RS at a minimum of 1 to 2 and max of 1 to 10 for the RS. Not sure if this still applies right now or that offering from 2011 has expired.

Either way they would have to implement a high RS ratio for there to be any significant push since this is still trading in the 0.02 cent range.

Also as you mentioned its interesting that they submitted all the work to the DCIG in India and expected an answer at the end of 2013 and since then we have not heard much in-regards to India approval except now from the interview.

When is the next CC....Mid May?

Molen on the CC last night mentioned that there could be a possible dividend payout. Does anyone know what kind of payout that could be? I know he mentioned if it actually happens it would be in about 3-4 weeks. The CC last night was the best one yet very transparent and I like the open shareholder forum.

The most important question for this upcoming CC is, The 3000 ton order that he PR in Jan'15 and why has it not been filled and a date on when it will be shipped out and VGPR starts making a profit. Once that order ships that will start to increase the pps.

Hi Tangerine,
I agree at some point they will get bought out by a bigger company, what would be your thoughts on a buyout price?

So is this CC going to be on Pot Talk radio again?

Once Elite has ELI 200 approved in Q1 2016, what are thoughts on sales and marketing? I know this can be a very expensive process with hiring a sales force and the money to market a product. Im thinking a possible partnership for this area...thoughts?

The biggest thing that Molen can do to boost investor confidence is by putting out a PR that the 3,000 ton order has been filled and shipped and we made a profit of $600,000 like he has stated before. Additionally, he really needs to have another conference call with the share holders, that is the most effective way to increase confidence.

The clinical trial for ELI 200 that you posted, is this for the Phase 3 that is required by the FDA? I noticed that it was initiated in Feb and is completing March. However I know from the CC they could not initiate the Phase 3 until they received feedback from the FDA.

Good news for us Elite longs...Purdue's ADT is not working as intended! http://www.newsmax.com/Health-News/oxycontin-hard-abuse/2015/03/13/id/630055/

Im a new investor and 1st posting on this message board, I just wanted to know if anyone had a status update on the trial that PPHM vs CSM that has been going on for the past couple of years? Has there been any time frame as to when this would be over, this definitely would be a hughe boost to the company and shareholders if they were to win!

Just noticed that on google finance that there is a delay in the stock...any ideas??

I just listened to the first couple of conference calls from VGPR since Im relatively new to the company as an investor. I just wanted to know if anybody could update the dividend that Molen was possibly talking about and when the next CC would be...thanks!

When is the next CC?

After the CC I'am still very confident in Elite. This minor delay will push us back only a few months. I'm hoping that they don't go the route of a reverse split(as mentioned in the CC as a possible route for uplisting) when the decide to uplist at the beginning of next year. I personally don't think they will need to just bc of the approval of ELI-200 along with other catalyst (accepted NDA, launching of other generics etc..) this year should kick the pps up. Also awhile back I email Dianne Will about a reverse split and she says they have no plan on going that route as it deters investors.

Does anyone know when the next conference call and financials are due....Im assuming around mid Feb.

Does anyone no when the next CC is scheduled for, Im assuming its around Feb 13 or 14 since this is when they had is last year.

First time posting to ihub.....I think this is a great stock and have been hold for about a year and definitely think 2015 will be great with the NDA submission and later on approval of Eli-200
I also came across a company called Egalet Corp. (EGLT) which is very similar to elite, except for all the generics that elite has and this company today is around ~$7 per share...something I think elite should be around and will eventually get to.